MedPath

MRA/fMRI Study of Spontaneous Migraine

Conditions
Headache Versus Non-headache Day
Registration Number
NCT01471314
Lead Sponsor
Glostrup University Hospital, Copenhagen
Brief Summary

The purpose of this study is to examine migraineurs during spontaneous migraine attacks without aura, using high resolution magnetic resonance imaging (MRI), to study following:

* Changes in resting state blood-oxygenation-level-dependent-signal (BOLD-signal) using functional MRI (fMRI).

* Changes in circumferences of intra- and extracranial arteries using MR-angiography (MRA).

* Changes in regional and global cerebral blood flow (CBF) using the arterial spin labeling (ASL) method.

Moreover to perform diffusion tensor imaging (DTI) scans during spontaneous migraine attacks.

The migraine specific drug sumatriptan will be given to relieve pain and the effect will be registered using MRA and fMRI if possible.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
Not specified
Inclusion Criteria
  • Migraine without aura according to IHS criteria.
Exclusion Criteria
  • Other primary headaches.
  • Tension-type headache more than 5 days/month.
  • Use of anti-pain medication before the scanning on the examination day.
  • Pregnant or nursing women.
  • Contraindication for MR scan.
  • Anamnestic or clinical signs of cardiovascular or cerebrovascular disease, unregulated psychiatric disease or drug misuse.
  • Other clinical conditions assessed by the examining doctor.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Glostrup Hospital, Faculty of Health Sciences, University of Copenhagen

🇩🇰

Glostrup, Denmark

Glostrup Hospital, Faculty of Health Sciences, University of Copenhagen
🇩🇰Glostrup, Denmark
Faisal Amin, MD, PhD student
Contact
+4538633066
famoam01@regionh.dk

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.